Proactive Investors - Run By Investors For Investors

Mediclinic won’t make a fresh swoop for Spire as takeover talks break down

Mediclinic hinted last week that it was considering reviving its interest in Spire after having a £1.2bn offer rejected last month
Murrayfield hospital sign
Mediclinic snapped up a stake in Spire back in 2015 as part of its plan to expand outside of its home South African market

Shares in Mediclinic International Plc (LON:MDC) headed lower on Monday after the company said it will not make a further offer for fellow private hospital group Spire Healthcare Group PLC (LON:SPI).

After having an offer turned down in October, South Africa-based group Mediclinic said last week it was mulling the possibility of a fresh swoop although it has now canned that idea following a breakdown in talks.

READ: Mediclinic downgraded to 'neutral' by JP Morgan Cazenove

South Africa-based Mediclinic saw its share price fall 35% to 539p in early deals, while Spire shares dived by 5% to 256.3p.

At the end of last month, Spire – in which Mediclinic holds a stake of almost 30% – rejected an offer which valued it at £1.2bn.

As a result, Mediclinic had until 5pm today (UK time) to either make a new offer or walk away. By choosing the latter, under City takeover rules it now has to wait another six months before it can make another bid unless there is a change in circumstances.

READ: Mediclinic gets a shot in the arm from reported Adu Dhabi regulatory change

“Mediclinic is disappointed that it could not reach an agreement with the independent directors of Spire,” the company said after talks between the two collapsed over the weekend.

Mediclinic added that it will remain a “supportive shareholder”.

View full MDC profile View Profile

Mediclinic International Plc Timeline

Related Articles

Sativa
April 02 2019
Geremy Thomas, founder and chief executive of Sativa, said the company has made significant progress since it started trading on NEX.
Weight loss
January 07 2019
A deal with Indian firm Zeon Lifesciences in January is the ninth deal the firm has secured for the weight loss product
harley street
May 10 2019
Work at Advanced Onco’s Harley Street facility is due to complete within the next few months, and the first patient treated by LIGHT is slated for the second half of 2020

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use